A detailed history of Journey Advisory Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Journey Advisory Group, LLC holds 20,233 shares of ABT stock, worth $2.13 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
20,233
Previous 20,541 1.5%
Holding current value
$2.13 Million
Previous $2.26 Million 1.73%
% of portfolio
0.28%
Previous 0.31%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$109.52 - $120.96 $33,732 - $37,255
-308 Reduced 1.5%
20,233 $2.3 Million
Q4 2023

Feb 12, 2024

SELL
$90.19 - $110.4 $4,058 - $4,968
-45 Reduced 0.22%
20,541 $2.26 Million
Q3 2023

Nov 15, 2023

SELL
$95.53 - $114.62 $11,177 - $13,410
-117 Reduced 0.57%
20,586 $1.99 Million
Q2 2023

Aug 09, 2023

SELL
$100.78 - $112.29 $294,076 - $327,662
-2,918 Reduced 12.35%
20,703 $2.26 Million
Q1 2023

May 04, 2023

SELL
$96.86 - $114.01 $747,662 - $880,043
-7,719 Reduced 24.63%
23,621 $2.39 Million
Q4 2022

Feb 07, 2023

SELL
$95.06 - $111.52 $348,585 - $408,943
-3,667 Reduced 10.48%
31,340 $3.44 Million
Q3 2022

Nov 09, 2022

SELL
$96.76 - $112.03 $422,841 - $489,571
-4,370 Reduced 11.1%
35,007 $3.39 Million
Q2 2022

Aug 02, 2022

BUY
$102.07 - $123.37 $436,859 - $528,023
4,280 Added 12.19%
39,377 $4.31 Million
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $279,006 - $340,230
2,447 Added 7.49%
35,097 $4.15 Million
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $37,778 - $46,257
327 Added 1.01%
32,650 $4.6 Million
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $45,030 - $49,817
386 Added 1.21%
32,323 $3.82 Million
Q2 2021

Aug 13, 2021

BUY
$105.79 - $124.53 $99,865 - $117,556
944 Added 3.05%
31,937 $3.7 Million
Q1 2021

May 11, 2021

BUY
$108.84 - $128.23 $52,569 - $61,935
483 Added 1.58%
30,993 $3.71 Million
Q4 2020

Jan 19, 2021

BUY
$105.0 - $114.42 $3.2 Million - $3.49 Million
30,510 New
30,510 $3.34 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $184B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Journey Advisory Group, LLC Portfolio

Follow Journey Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Journey Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Journey Advisory Group, LLC with notifications on news.